The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey
Author
Kilickap, S.
Sakalar, T.
Tatli, A. M.
Bugdayci, F. Basol
Uysal, M.
Demirkazik, A.
Bilgin, B.
Yildiz, B.
Karaagac, M.
Okutur, K.
Sakin, A.
Cabuk, D.
Eralp, Y.
Alan, O.
Demirci, U.
Cicin, I.
Olmez, O. F.
Metadata
Show full item recordCollections
- Bildiri [64839]